FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

764323003: Product containing ocrelizumab in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3711068012 Ocrelizumab-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3711069016 Product containing ocrelizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647627016 Product containing ocrelizumab in parenteral dosage form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647628014 Ocrelizumab in parenteral dosage form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647629018 Product containing ocrelizumab in parenteral dosage form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3711068012 Ocrelizumab-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3711069016 Product containing ocrelizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5502621000241119 produit contenant de l'ocrélizumab sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5502621000241119 produit contenant de l'ocrélizumab sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ocrelizumab-containing product in parenteral dose form Is a Product manufactured as parenteral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Ocrelizumab-containing product in parenteral dose form Is a Product containing ocrelizumab (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Ocrelizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ocrelizumab true Inferred relationship Existential restriction modifier (core metadata concept) 1
Ocrelizumab-containing product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only ocrelizumab in parenteral dose form (medicinal product form) Is a True Ocrelizumab-containing product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start